DEFB130B
gene geneOn this page
Summary
DEFB130B (defensin beta 130B, HGNC:39814) is a protein-coding gene on chromosome 8p23.1, encoding Beta-defensin 130B (P0DP73). Antimicrobial host-defense peptide.
Predicted to enable CCR6 chemokine receptor binding activity and chemoattractant activity. Predicted to be involved in cell chemotaxis and defense response to bacterium. Located in cytosol.
Source: NCBI Gene 100133267 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001195257
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:39814 |
| Approved symbol | DEFB130B |
| Name | defensin beta 130B |
| Location | 8p23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000233050 |
| Ensembl biotype | protein_coding |
| Entrez | 100133267 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000437818
RefSeq mRNA: 1 — MANE Select: NM_001195257
NM_001195257
CCDS: CCDS56524
Canonical transcript exons
ENST00000437818 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001591939 | 12064389 | 12064570 |
| ENSE00001619111 | 12071690 | 12071747 |
Expression profiles
Bgee: expression breadth tissue_specific, 6 present calls, max score 37.20.
Top tissues by expression
114 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| urinary bladder | UBERON:0001255 | 27.88 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| muscle of leg | UBERON:0001383 | 24.85 | gold quality |
| leukocyte | CL:0000738 | 24.80 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| monocyte | CL:0000576 | 24.52 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| frontal cortex | UBERON:0001870 | 23.83 | gold quality |
| gastrocnemius | UBERON:0001388 | 23.63 | gold quality |
| kidney | UBERON:0002113 | 23.19 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.05 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb47 | ENSMUSG00000075573 |
| rattus_norvegicus | Defb41 | ENSRNOG00000085557 |
Paralogs (6): DEFB4A (ENSG00000171711), DEFB4B (ENSG00000177257), DEFB109C (ENSG00000205989), DEFB109B (ENSG00000206034), DEFB130A (ENSG00000232948), DEFB109D (ENSG00000254866)
Protein
Protein identifiers
Beta-defensin 130B — P0DP73 (reviewed: P0DP73)
All UniProt accessions (1): P0DP73
UniProt curated annotations — full annotation on UniProt →
Function. Antimicrobial host-defense peptide. Has an antiplasmodial activity.
Subcellular location. Secreted.
Tissue specificity. Expressed on differentiated macrophage phagocytizing plasmodium falciparum-parasitized erythrocytes.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (1): NP_001182186* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001855 | Defensin_beta-like | Domain |
Pfam: PF00711
UniProt features (4 total): disulfide bond 2, signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DP73-F1 | 83.22 | 0.34 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 38–53, 43–60
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 23 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_CELL_CHEMOTAXIS, GOBP_TAXIS, GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, GOMF_SIGNALING_RECEPTOR_BINDING, GOBP_POSITIVE_CHEMOTAXIS, GOMF_CHEMOATTRACTANT_ACTIVITY, GOMF_CCR_CHEMOKINE_RECEPTOR_BINDING, GOBP_RESPONSE_TO_BACTERIUM, GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY, GOMF_CCR6_CHEMOKINE_RECEPTOR_BINDING, REACTOME_ANTIMICROBIAL_PEPTIDES, GOBP_LOCOMOTION, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS
GO Biological Process (5): defense response to bacterium (GO:0042742), cell chemotaxis (GO:0060326), defense response (GO:0006952), positive chemotaxis (GO:0050918), defense response to other organism (GO:0098542)
GO Molecular Function (2): CCR6 chemokine receptor binding (GO:0031731), chemoattractant activity (GO:0042056)
GO Cellular Component (2): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| defense response | 2 |
| chemotaxis | 2 |
| response to bacterium | 1 |
| cell migration | 1 |
| cellular response to chemical stimulus | 1 |
| response to stress | 1 |
| response to other organism | 1 |
| CCR chemokine receptor binding | 1 |
| receptor ligand activity | 1 |
| positive chemotaxis | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A096LNP1, A4H206, A4H207, A4H208, A4H209, A4H212, A4H213, P0C8A5, P0C8B0, P0DP73, P0DP74, P59861, P82020, P82172, Q30KJ3, Q30KJ5, Q30KJ6, Q30KJ8, Q30KJ9, Q30KK8, Q30KL4, Q30KL6, Q30KM9, Q30KP5, Q30KP6, Q30KP8, Q30KQ1, Q30KQ6, Q30KQ7, Q30KQ9, Q32ZF3, Q32ZF7, Q32ZG3, Q32ZH4, Q32ZH5, Q32ZH6, Q32ZI1, Q32ZI2, Q4QY38, Q6QLQ7
Diamond homologs: P0DP73, P0DP74, P0DY26, P0DY27, Q30KJ9, Q30KL7, Q30KR1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
191 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:12071482:TGA:T | donor_gain | 0.9200 |
| 8:12071684:TCTTA:T | donor_loss | 0.9100 |
| 8:12071685:CTTAC:C | donor_loss | 0.9100 |
| 8:12071686:TTAC:T | donor_loss | 0.9100 |
| 8:12071687:TACCT:T | donor_loss | 0.9100 |
| 8:12071688:A:AT | donor_loss | 0.9100 |
| 8:12071541:A:AC | donor_gain | 0.8100 |
| 8:12071577:T:TA | donor_gain | 0.7900 |
| 8:12071688:A:AC | donor_gain | 0.7700 |
| 8:12071689:C:CC | donor_gain | 0.7700 |
| 8:12071488:C:CA | donor_gain | 0.7600 |
| 8:12064566:CTTTC:C | acceptor_gain | 0.7200 |
| 8:12066455:C:CA | acceptor_gain | 0.6800 |
| 8:12071690:C:A | donor_loss | 0.6200 |
| 8:12064567:TTTCC:T | acceptor_loss | 0.6100 |
| 8:12064568:TTCC:T | acceptor_loss | 0.6100 |
| 8:12064571:CTA:C | acceptor_loss | 0.6100 |
| 8:12064572:T:TC | acceptor_loss | 0.6100 |
| 8:12064573:A:C | acceptor_loss | 0.6000 |
| 8:12064574:C:CT | acceptor_loss | 0.6000 |
| 8:12064585:A:C | acceptor_loss | 0.6000 |
| 8:12064587:T:C | acceptor_loss | 0.6000 |
| 8:12071627:T:C | donor_gain | 0.6000 |
| 8:12064586:T:C | acceptor_loss | 0.5900 |
| 8:12064576:C:CT | acceptor_loss | 0.5800 |
| 8:12064575:A:T | acceptor_loss | 0.5700 |
| 8:12064597:CAT:C | acceptor_loss | 0.5700 |
| 8:12064599:T:TC | acceptor_loss | 0.5700 |
| 8:12068270:G:C | donor_gain | 0.5600 |
| 8:12064579:GAAGA:G | acceptor_loss | 0.5500 |
AlphaMissense
505 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1002440634 (8:12064893 CA>C), RS1002650972 (8:12064675 T>C), RS1003241928 (8:12066649 G>T), RS1004208916 (8:12071185 C>A), RS1004455692 (8:12072870 C>A), RS1007369301 (8:12066595 A>C,G), RS1007426537 (8:12066321 C>A,G), RS1007957129 (8:12070908 T>G), RS1008846287 (8:12069834 T>A,C), RS1010875206 (8:12065777 A>T), RS1011013965 (8:12065049 C>G), RS1012002682 (8:12067003 G>A,C), RS1012361871 (8:12068861 G>C), RS1017487123 (8:12066126 T>C), RS1017853679 (8:12066325 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.